These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23591418)

  • 1. Bivalirudin for carotid artery stenting: a new approach on the HORIZON(s)?
    Armstrong EJ; Laird JR
    Circ Cardiovasc Interv; 2013 Apr; 6(2):125-7. PubMed ID: 23591418
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemorrhagic and ischemic outcomes after bivalirudin versus unfractionated heparin during carotid artery stenting: a propensity score analysis from the NCDR.
    Wayangankar SA; Abu-Fadel MS; Aronow HD; Kennedy KF; Gupta R; Yeh RW; Gray WA; Rosenfield K; Hennebry TA
    Circ Cardiovasc Interv; 2013 Apr; 6(2):131-8. PubMed ID: 23532554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: bivalirudin is a safe and effective anticoagulant in the percutaneous treatment of complex infrainguinal disease.
    Walker CM
    J Endovasc Ther; 2010 Feb; 17(1):37-8. PubMed ID: 20199264
    [No Abstract]   [Full Text] [Related]  

  • 4. Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty.
    Bonello L; de Labriolle A; Roy P; Steinberg DH; Pinto Slottow TL; Xue Z; Kaneshige K; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2009; 10(3):156-61. PubMed ID: 19595396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in percutaneous peripheral intervention: a single-center experience.
    Sheikh IR; Ahmed SH; Mori N; Gupta A; Mewissen M; Allaqaband S; Bajwa T
    JACC Cardiovasc Interv; 2009 Sep; 2(9):871-6. PubMed ID: 19778776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oldies but goodies.
    Butman SM
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):436-7. PubMed ID: 19681122
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel approaches for preventing or limiting events (Naples) III trial: randomized comparison of bivalirudin versus unfractionated heparin in patients at increased risk of bleeding undergoing transfemoral elective coronary stenting.
    Briguori C; Visconti G; Focaccio A; Donahue M; Golia B; Selvetella L; Ricciardelli B
    JACC Cardiovasc Interv; 2015 Mar; 8(3):414-423. PubMed ID: 25703878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalirudin during primary PCI in acute myocardial infarction.
    Stone GW; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Dangas G; Wong SC; Kirtane AJ; Parise H; Mehran R;
    N Engl J Med; 2008 May; 358(21):2218-30. PubMed ID: 18499566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.
    Mehran R; Lansky AJ; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Wong SC; Nikolsky E; Gambone L; Vandertie L; Parise H; Dangas GD; Stone GW;
    Lancet; 2009 Oct; 374(9696):1149-59. PubMed ID: 19717185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention.
    Lemesle G; De Labriolle A; Bonello L; Syed A; Collins S; Maluenda G; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):428-35. PubMed ID: 19360860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors.
    Bangalore S; Toklu B; Kotwal A; Volodarskiy A; Sharma S; Kirtane AJ; Feit F
    BMJ; 2014 Nov; 349():g6419. PubMed ID: 25389143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital safety and effectiveness of bivalirudin in percutaneous peripheral interventions: data from a real-world registry.
    Shammas NW; Shammas GA; Jerin M; Dippel EJ; Shammas AN
    J Endovasc Ther; 2010 Feb; 17(1):31-6. PubMed ID: 20199263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.
    Kastrati A; Neumann FJ; Mehilli J; Byrne RA; Iijima R; Büttner HJ; Khattab AA; Schulz S; Blankenship JC; Pache J; Minners J; Seyfarth M; Graf I; Skelding KA; Dirschinger J; Richardt G; Berger PB; Schömig A;
    N Engl J Med; 2008 Aug; 359(7):688-96. PubMed ID: 18703471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.
    Steinberg DH; Shah P; Kinnaird T; Pinto Slottow TL; Roy PK; Okabe T; Bonello L; de Labriolle A; Smith KA; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jul; 102(2):160-4. PubMed ID: 18602514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.
    Iijima R; Ndrepepa G; Mehilli J; Byrne RA; Schulz S; Neumann FJ; Richardt G; Berger PB; Schömig A; Kastrati A
    Eur Heart J; 2009 Feb; 30(3):290-6. PubMed ID: 19147609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study).
    Patti G; Pasceri V; D'Antonio L; D'Ambrosio A; Macrì M; Dicuonzo G; Colonna G; Montinaro A; Di Sciascio G
    Am J Cardiol; 2012 Aug; 110(4):478-84. PubMed ID: 22583760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorrhagic and ischemic outcomes of Heparin vs. Bivalirudin in carotid artery stenting: A meta-analysis of studies.
    Omran J; Abdullah O; Abu-Fadel M; Gray WA; Firwana B; Drachman DE; Mahmud E; Aronow HD; White CJ; Al-Dadah AS
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):746-753. PubMed ID: 27526953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Approaches for Preventing or Limiting Events (NAPLES III) Trial: randomised comparison of bivalirudin versus unfractionated heparin in patients at high risk of bleeding undergoing elective coronary stenting throught the femoral approach. rationale and design.
    Briguori C; Visconti G; Focaccio A; Donahue M; Golia B; Selvetella L; Ricciarelli B
    Cardiovasc Drugs Ther; 2014 Jun; 28(3):273-9. PubMed ID: 24781074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivalirudin (Angiomax) for angioplasty.
    Med Lett Drugs Ther; 2001 Apr; 43(1103):37-8. PubMed ID: 11331441
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
    Verdoia M; Barbieri L; Parodi G; Bellandi B; Schaffer A; Suryapranata H; De Luca G
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):553-565. PubMed ID: 28471057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.